1. Home
  2. RWAY vs RNAC Comparison

RWAY vs RNAC Comparison

Compare RWAY & RNAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Runway Growth Finance Corp.

RWAY

Runway Growth Finance Corp.

HOLD

Current Price

$6.34

Market Cap

277.7M

Sector

N/A

ML Signal

HOLD

Logo Cartesian Therapeutics Inc.

RNAC

Cartesian Therapeutics Inc.

HOLD

Current Price

$6.55

Market Cap

243.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RWAY
RNAC
Founded
2015
2007
Country
United States
United States
Employees
N/A
75
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
277.7M
243.0M
IPO Year
N/A
2016

Fundamental Metrics

Financial Performance
Metric
RWAY
RNAC
Price
$6.34
$6.55
Analyst Decision
Buy
Strong Buy
Analyst Count
6
5
Target Price
$9.50
$34.00
AVG Volume (30 Days)
700.1K
149.1K
Earning Date
05-07-2026
05-11-2026
Dividend Yield
21.54%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$2,797,000.00
Revenue This Year
$1.26
N/A
Revenue Next Year
$1.25
N/A
P/E Ratio
$5.70
N/A
Revenue Growth
N/A
N/A
52 Week Low
$6.22
$5.60
52 Week High
$11.41
$14.56

Technical Indicators

Market Signals
Indicator
RWAY
RNAC
Relative Strength Index (RSI) 39.81 43.02
Support Level N/A $6.07
Resistance Level $6.97 $6.60
Average True Range (ATR) 0.21 0.69
MACD -0.02 -0.19
Stochastic Oscillator 15.53 16.89

Price Performance

Historical Comparison
RWAY
RNAC

About RWAY Runway Growth Finance Corp.

Runway Growth Finance Corp is a specialty finance company focused on providing senior secured loans to high-growth-potential companies in technology, life sciences, healthcare information and services, business services, select consumer services and products, and other high-growth industries. The company has Investments in the United States, Germany, and UK, Canada, Netherlands, with the majority of its portfolio invested in the United States. The company's investment objective is to maximize its total return to its stockholders through current income on its loan portfolio, and secondarily through capital gain on its warrants and other equity positions.

About RNAC Cartesian Therapeutics Inc.

Cartesian Therapeutics Inc is a clinical-stage biopharmaceutical company pioneering cell therapy for the treatment of autoimmune diseases. The company uses technology and a manufacturing platform to introduce mRNA into cells to provide a therapeutic effect to patients suffering from a variety of autoimmune conditions. Unlike DNA, mRNA degrades naturally over time without integrating into the cell's genetic material.

Share on Social Networks: